Physician

Felicia Hare Wheeler, M.D.

According to 2025 Medicare claims, Felicia Wheeler, M.D. (NPI: 1730522053) practices hematology/oncology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is TENNESSEE CANCER SPECIALISTS PLLC (NPI: 1841228871; TIN: 200677400) and primary practice location at 37849-4052. Wheeler is affiliated with the University Health ACO, LLC (ACO ID: A3791), participating under the MSSP model.

Wheeler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 223 traditional Medicare patients, billed 505 HCPCS/CPT codes, and received $42,751 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 598 prescription claims across 158 beneficiaries totaling $708,051 in drug costs, led by Xtandi (Enzalutamide). 2022 DME data shows 52 claims. Open Payments data shows 116 records totaling $2,681. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $22,384 to $708,051. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	108	335	$16,577
2020	214	1,318	$51,775
2021	225	1,412	$59,692
2022	194	741	$38,809
2023	192	469	$40,235
2024	223	505	$42,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	498	$22,384
2016	30	369	$14,700
2017	18	44	$1,448
2018	N/R	N/R	N/R
2019	43	92	$163,555
2020	103	480	$770,173
2021	143	739	$1,219,197
2022	154	688	$922,842
2023	140	578	$745,908
2024	158	598	$708,051

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	52	$1,409
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	63	63	$137
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	57	101	$104
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	27	27	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	97	183	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	80	97	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	12	360	$153,191
Eliquis	Apixaban	34	1,140	$21,890
Ondansetron Hcl	Ondansetron Hcl	58	1,534	$1,979
Anastrozole	Anastrozole	131	9,660	$1,892
Promethazine Hcl	Promethazine Hcl	48	1,316	$783

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$2,681	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Felicia Hare Wheeler, M.D.?

Tedicare shows public-source Medicare data for Felicia Hare Wheeler, M.D. (NPI 1730522053), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Felicia Hare Wheeler, M.D. have ACO affiliation data?

Felicia Hare Wheeler, M.D. is shown with ACO affiliation data for University Health ACO, LLC (MSSP, ACO ID A3791).

What billing organization is linked to Felicia Hare Wheeler, M.D.?

Felicia Hare Wheeler, M.D. is linked to TENNESSEE CANCER SPECIALISTS PLLC (billing NPI 1841228871) in the available physician profile data.

Does Felicia Hare Wheeler, M.D. have Open Payments data?

Felicia Hare Wheeler, M.D. has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.